Edition:
United Kingdom

Insider Trading: argenx SE (ARGX.BR)

ARGX.BR on Brussels Stock Exchange

133.20EUR
22 Jul 2019
Change (% chg)

-- (--)
Prev Close
€133.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
106,381
52-wk High
€135.70
52-wk Low
€54.30

All Insider Trades

Institutional Holders

% Shares Owned: 36.39%
# of Holders: 98
Total Shares Held: 13,715,661
3 Mo. Net Change: 15,017
# New Positions: 7
# Closed Positions: 4
# Increased Positions: 32
# Reduced Positions: 20
# Net Buyers: 12

Officers & Directors

Name Age Since Current Position

Peter Verhaeghe

60 2014 Non-Executive Independent Chairman of the Board

Tim Van Hauwermeiren

46 2014 Chief Executive Officer, Member of the Board

Werner Lanthaler

50 2014 Non-Executive Independent Vice Chairman of the Board

Eric Castaldi

53 2014 Chief Financial Officer

Hans de Haard

58 Chief Scientific Officer

Rebecca McLeod

Vice President Marketing

Trevor Leighton

Vice President Market Access

Michael Saunders

VP External Research

Luc Van Rompaey

VP Translational Medicine

Debbie Allen

58 Senior Director, Business Development

Dirk Beeusaert

53 2017 General Counsel

Torsten Dreier

53 2008 Chief Development Officer

Nicolas Leupin

44 2016 Chief Medical Officer

Joseph De Bethizy

68 2015 Non-Executive Independent Member of the Board

Pamela Klein

57 2016 Non-Executive Independent Member of the Board

David Lacey

66 2014 Non-Executive Independent Member of the Board

A.A. Rosenberg

66 2017 Non-Executive Independent Member of the Board